A Resolution designating March 25, 2026, as "Autoimmune Hemolytic Anemia Awareness Day" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This resolution officially recognizes March 25, 2026, as "Autoimmune Hemolytic Anemia Awareness Day" in Pennsylvania. The resolution aims to raise awareness about this rare form of anemia, where the body’s immune system attacks red blood cells. It highlights the symptoms, potential complications, and ongoing research efforts related to this condition.
Key provisions
- Designates March 25, 2026, as Autoimmune Hemolytic Anemia Awareness Day.
- Provides context on the nature of Autoimmune Hemolytic Anemia (AIHA).
- Details the symptoms associated with AIHA.
- Distinguishes between primary and secondary forms of AIHA.
- Notes the potential for delayed diagnosis by medical professionals.
- Acknowledges the potential for serious complications if left untreated.
- Highlights ongoing research and clinical trials for potential treatments.
Who is affected
- Individuals with Autoimmune Hemolytic Anemia
- Families and caregivers of those with AIHA
- Medical professionals involved in diagnosing and treating blood disorders
Notable changes
- This resolution establishes a dedicated day to raise awareness about a specific, rare blood disorder.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 1465 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Cosponsors
Christine Tartaglione
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours